mannosebind
lectin
mbl
key
solubl
pathogen
recognit
protein
innat
immun
system
bind
specif
mannosecontain
glycan
surfac
microbi
agent
initi
complement
activ
via
lectin
pathway
prior
studi
show
mbldepend
activ
complement
cascad
neutral
insect
cellderiv
west
nile
viru
wnv
cell
cultur
restrict
pathogenesi
mice
investig
antivir
activ
mbl
infect
dengu
viru
denv
relat
flaviviru
use
panel
sera
mous
strain
defici
differ
complement
compon
show
inhibit
infect
insect
celland
mammalian
cellderiv
denv
primarili
depend
lectin
pathway
human
mbl
also
bound
denv
neutral
infect
four
denv
serotyp
complement
activationdepend
independ
pathway
experi
human
serum
individu
inher
variat
level
mbl
blood
show
direct
correl
concentr
mbl
neutral
denv
sampl
high
level
mbl
blood
neutral
denv
effici
lower
level
studi
suggest
allel
variat
mbl
human
may
impact
complementdepend
control
denv
pathogenesi
citat
avirutnan
p
et
al
complementmedi
neutral
dengu
viru
requir
mannosebind
lectin
mbio
member
flavivirida
famili
also
includ
west
nile
viru
wnv
japanes
enceph
viru
yellow
fever
viru
denv
infect
continu
spread
global
estim
human
million
infect
million
clinic
sever
case
death
per
year
follow
mosquito
inocul
denv
infect
human
clinic
silent
asymptomat
caus
syndrom
rang
febril
ill
classic
dengu
fever
df
lifethreaten
hemorrhag
vascular
permeabl
syndrom
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
although
pathogenesi
denv
infect
remain
controversi
antibodydepend
enhanc
denv
infect
receptorbear
cell
effect
virul
strain
proinflammatori
cytokin
storm
secondari
exuber
activ
poorli
lytic
crossreact
cell
excess
complement
activ
suggest
possibl
mechan
review
refer
rna
genom
denv
contain
gene
encod
three
structur
protein
capsid
c
precursor
membran
membran
prmm
envelop
e
seven
nonstructur
protein
matur
dengu
virion
particl
compos
nucleocapsid
associ
rna
genom
surround
lipid
bilay
prmm
e
protein
insert
e
protein
two
potenti
nlink
glycosyl
site
domain
ii
uniqu
denv
complex
domain
conserv
flavivirus
denv
util
nlink
glycan
interact
cell
surfac
attach
lectin
dcsign
facilit
bind
entri
host
cell
denv
enter
cell
via
clathrinmedi
endocytosi
fuse
acid
endosom
viral
genom
penetr
cytoplasm
target
cell
follow
protein
translat
rna
replic
immatur
virion
assembl
within
endoplasm
reticulum
pass
golgi
transgolgi
network
viru
matur
cleavag
prm
protein
promot
furinlik
proteas
activ
complement
system
occur
via
three
converg
pathway
refer
classic
lectin
altern
pathway
classic
pathway
activ
trigger
bind
antigenantibodi
complex
surfac
pathogen
lectin
pathway
initi
mannosebind
lectin
mbl
ficolin
recognit
carbohydr
structur
surfac
microb
apoptot
cell
bind
mbl
ficolin
activ
mblassoci
serin
proteas
masp
three
masp
protein
identifi
ie
respons
cleavag
form
convertas
mbl
also
shown
induc
activ
independ
bypass
pathway
altern
pathway
constitut
activ
low
level
spontan
hydrolysi
also
serv
amplifi
activ
classic
lectin
pathway
bind
back
convertas
classic
altern
pathway
gener
convertas
enzym
cleav
gener
anaphylatoxin
promot
assembl
membran
attack
lytic
complex
mbl
calciumdepend
ctype
lectin
recogn
adjac
equatori
monosaccharid
hydroxyl
group
present
mannos
nacetylglucosamin
glcnac
fucos
display
rang
microorgan
human
mbl
encod
gene
polymorph
result
highli
variabl
mbl
activ
human
plasma
three
singlenucleotid
polymorph
snp
allel
b
codon
c
codon
codon
locat
exon
affect
structur
function
integr
protein
addit
snp
promot
hl
variant
posit
xy
variant
posit
untransl
pq
variant
posit
region
gene
influenc
basal
level
mbl
serum
low
mbl
serum
level
variant
mbl
allel
associ
enhanc
suscept
infect
young
children
immunocompromis
patient
review
refer
adult
low
serum
mbl
concentr
suggest
influenc
diseas
progress
associ
hiv
hepat
b
hepat
c
herp
simplex
viru
infect
although
complement
system
suggest
play
role
denv
pathogenesi
particular
secondari
infect
role
protect
denv
remain
uncertain
show
human
mbl
bound
insect
celland
mammalian
cellderiv
denv
neutral
infect
denv
serotyp
complement
activationdepend
independ
pathway
moreov
observ
direct
correl
concentr
mbl
human
serum
neutral
denv
studi
suggest
allel
variat
mbl
human
may
impact
complementdepend
control
denv
infect
previou
studi
show
serum
wildtyp
mice
neutral
gener
insect
cell
mammalian
cell
studi
neutral
activ
lost
serum
mbla
mblc
mblac
mice
use
suggest
lectin
pathway
contribut
complementmedi
neutral
denv
serotyp
howev
studi
address
whether
neutral
requir
activ
complement
activ
pathway
downstream
compon
evalu
pretreat
insect
cell
deriv
mammalian
cell
vero
deriv
sera
wild
type
sever
congen
mous
strain
defici
differ
complement
compon
analog
result
insect
cellderiv
wnv
neutral
insect
celland
mammalian
cellderiv
depend
mbl
mblassoci
serin
proteas
fig
c
thu
classic
complement
activ
pathway
format
membran
attack
complex
necessari
neutral
serum
absenc
doubl
knockout
dko
almost
abrog
inhibitori
effect
serum
mbldepend
neutral
requir
activ
complement
system
howev
defici
either
result
partial
loss
neutral
phenotyp
suggest
neutral
mbl
occur
canon
lectin
pathway
bypass
pathway
complement
activ
fig
absenc
factor
b
fb
factor
fd
neutral
also
partial
inhibit
suggest
contribut
altern
pathway
probabl
via
amplif
loop
result
greater
deposit
virion
surfac
fig
serum
mice
neutral
denv
infect
level
similar
wildtyp
mice
mice
lack
b
cell
establish
natur
antibodi
contribut
significantli
serumdepend
neutral
notabl
antibodyindepend
serum
neutral
effici
even
highli
dilut
neat
serum
neutral
infect
fig
mbldepend
neutral
insect
celland
mammalian
cellderiv
mous
serum
confirm
complet
loss
neutral
presenc
excess
solubl
mannan
competitor
mbl
bind
fig
mbl
directli
bind
neutral
insect
cellderiv
independ
complement
activ
wherea
neutral
wnv
mbl
occur
insect
cellderiv
viru
mammalian
cellderiv
viru
form
suscept
mbldepend
complementmedi
inhibit
howev
neutral
insect
cellderiv
wildtyp
mous
serum
effici
mammalian
cellderiv
versu
neutral
serum
concentr
respect
p
fig
phenotyp
like
due
modif
highmannos
carbohydr
moieti
structur
protein
surfac
virion
produc
mammalian
cell
result
less
effici
recognit
mbl
test
direct
bind
mbl
develop
captur
enzymelink
immunosorb
assay
elisa
infecti
viru
bound
well
microtit
plate
coat
antidenv
prm
mutant
monoclon
antibodi
mab
purifi
recombin
mbl
bound
effici
immobil
insect
avirutnan
et
al
cellderiv
dosedepend
manner
expect
bind
ca
depend
block
solubl
mannan
fig
specif
interact
confirm
absenc
signal
isotyp
control
antihepat
c
viru
protein
mab
use
captur
antibodi
next
compar
rel
bind
mbl
insect
celland
mammalian
cellderiv
equival
amount
virus
judg
denv
eproteinspecif
mab
bound
captur
virion
fig
interrog
bind
mbl
elisa
notabl
purifi
mbl
preferenti
bound
insect
cellderiv
concentr
test
p
fig
dosedepend
bind
purifi
mbl
mammalian
cellderiv
also
ca
depend
inhibit
solubl
mannan
mbl
exist
oligom
homotrim
bind
higherord
oligomer
mbl
virus
could
caus
steric
interfer
structur
protein
virion
surfac
cognat
ligand
thu
restrict
infect
target
cell
test
pretreat
insect
cellderiv
purifi
mbl
form
oligom
similar
nativ
human
mbl
addit
monolay
cell
bind
physiolog
concentr
mbl
insect
cellderiv
fb
fd
antibodydefici
mice
prior
addit
monolay
cell
infect
determin
day
later
plaqu
assay
data
present
percent
neutral
given
complementdefici
antibodydefici
serum
compar
wildtyp
serum
error
bar
indic
standard
error
mean
sem
independ
experi
condit
perform
duplic
valu
significantli
differ
valu
wildtyp
serum
indic
asterisk
follow
p
p
p
b
serum
neutral
cellderiv
b
vero
cellderiv
denv
abolish
presenc
mannan
denv
preincub
increas
percentag
wildtyp
serum
presenc
absenc
mannan
gml
percentag
neutral
calcul
base
reduct
number
plaqu
given
condit
compar
heatinactiv
hi
wildtyp
serum
error
bar
indic
sem
independ
experi
perform
duplic
valu
significantli
differ
valu
wild
type
indic
asterisk
bracket
follow
p
p
p
e
model
denv
neutral
complement
mbl
bind
virion
surfac
initi
lectin
pathway
activ
result
deposit
bind
mbl
also
activ
masp
directli
cleav
without
activ
bypass
pathway
altern
pathway
amplif
loop
serv
gener
deposit
viru
absenc
complement
compon
neutral
infect
fig
nonetheless
effici
neutral
increas
significantli
p
presenc
complement
compon
serum
mblac
mice
especi
low
concentr
purifi
mbl
eg
gml
fig
expect
solubl
mannan
compet
bind
purifi
mbl
denv
inhibit
complementindepend
fig
complementdepend
fig
neutral
insect
cellderiv
contrast
purifi
mbl
fail
directli
neutral
propag
sever
mammalian
cell
type
includ
vero
cell
primari
human
monocytederiv
dendrit
cell
dc
primari
human
peripher
blood
monocyt
wnv
produc
insect
mammalian
cell
even
concentr
mbl
high
gml
physiolog
level
fig
see
fig
supplement
materi
contrast
human
mbl
purifi
mous
mbl
inhibit
insect
cellderiv
poorli
without
complement
activ
although
neutral
activ
greatli
enhanc
presenc
complement
compon
fig
combin
blood
level
mbl
mice
data
shown
result
begin
explain
lack
neutral
activ
serum
mice
fig
flaviviru
virion
dynam
structur
breath
higher
temperatur
impact
antibodi
neutral
wnv
denv
modul
epitop
access
phenomenon
could
import
antivir
immun
context
febril
respons
consist
bind
purifi
mbl
denv
increas
neutral
insect
cellderiv
room
temperatur
versu
p
room
temperatur
versu
p
versu
p
mammalian
cellderiv
absenc
addit
complement
compon
fig
b
temperatur
effect
specif
mbl
abolish
addit
solubl
mannan
occur
irrelev
protein
bovin
serum
albumin
bsa
anoth
collectin
neutral
insect
cellderiv
human
serum
depend
concentr
mbl
next
assess
relev
find
human
serum
initi
sera
two
healthi
adult
volunt
assay
neutral
consist
result
wildtyp
neutral
human
serum
serum
inhibit
infect
mbl
depend
neutral
abolish
presenc
solubl
mannos
mannos
second
competitor
ligand
mbl
use
instead
mannan
antimannan
antibodi
ubiquit
present
human
sera
mbldepend
neutral
mammalian
cellderiv
human
serum
less
effect
rel
insect
cellderiv
donor
serum
p
serum
p
donor
serum
p
serum
p
serum
p
also
notic
serum
donor
neutral
effici
donor
blood
mbl
level
human
vari
consider
due
least
five
common
genet
polymorph
human
gene
specul
ineffici
neutral
serum
donor
due
lower
serum
mbl
concentr
use
commerci
elisa
concentr
mbl
sera
donor
measur
ngml
respect
inde
reconstitut
serum
donor
purifi
mbl
level
donor
result
neutral
insect
cellderiv
degre
similar
serum
donor
fig
surpris
addit
even
high
concentr
gml
purifi
mbl
serum
donor
neutral
mammalian
cellderiv
fig
howev
addit
increas
percentag
fresh
fig
heatinactiv
fig
serum
donor
serum
donor
result
neutral
mammalian
cellderiv
result
abolish
solubl
mannos
establish
neutral
mammalian
cellderiv
donor
requir
mbl
serum
donor
particular
fig
f
investig
concentr
mbl
impact
abil
human
serum
neutral
obtain
sera
fifteen
addit
healthi
adult
volunt
includ
five
donor
known
polymorph
associ
chang
level
structur
function
protein
gene
tabl
first
measur
concentr
mbl
sera
fig
mbl
level
vari
wide
rang
ngml
gml
next
test
whether
nativ
form
mbl
human
serum
bound
similar
result
purifi
human
mbl
fig
b
mbl
serum
bound
immobil
insect
cellderiv
virion
fig
notabl
degre
bind
reflect
concentr
mbl
differ
serum
sampl
fig
posit
correl
observ
r
p
fig
expect
mbl
concentr
also
modul
effici
serumdepend
neutral
sera
individu
higher
blood
mbl
level
neutral
viru
effect
lower
mbl
level
fig
howev
weakli
neutral
activ
observ
serum
sampl
also
could
due
defici
complement
compon
especi
whose
function
level
influenc
sever
factor
includ
number
copi
gene
evalu
function
total
complement
hemolyt
activ
level
dose
complement
lyse
red
blood
cell
suspens
sera
measur
contrast
serum
mbl
concentr
fig
signific
differ
p
function
fig
fig
level
observ
among
donor
importantli
neutral
sera
donor
except
donor
antibodi
independ
mbl
specif
addit
excess
solubl
mannos
abrog
neutral
activ
fig
neutral
sera
donor
later
determin
contain
specif
igg
data
shown
mbl
independ
like
occur
activ
classic
complement
pathway
addit
high
level
specif
igg
serum
donor
may
interf
serum
mbl
bind
virion
result
rel
low
signal
captur
elisa
fig
overal
posit
correl
observ
neutral
serum
mbl
level
r
p
fig
notabl
sera
three
individu
donor
carri
structur
variant
mbl
allel
b
c
thu
markedli
reduc
mbl
level
also
low
neutral
activ
tabl
mammalian
cellderiv
less
effici
inhibit
human
serum
fig
c
higher
percentag
serum
use
neutral
assay
absenc
see
fig
supplement
materi
presenc
fig
mannos
despit
lower
level
inhibit
posit
correl
also
present
serum
mbl
level
neutral
mammalian
cellderiv
r
p
fig
mbl
neutral
denv
serotyp
complementdepend
independ
mechan
denv
complex
compris
four
antigen
relat
serotyp
signific
divers
amino
acid
level
therefor
extend
studi
mbl
serotyp
denv
consist
result
mbl
neutral
insect
cellderiv
via
complementdepend
fig
complementindepend
fig
mechan
human
sera
donor
contain
higher
level
mbl
neutral
insect
cellderiv
effici
sera
donor
p
p
fig
howev
sera
donor
despit
high
concentr
mbl
gml
donor
fail
neutral
insect
cellderiv
fig
nonetheless
reconstitut
serum
donor
purifi
human
mbl
gml
neutral
infect
fig
confirm
complementmedi
neutral
insect
cellderiv
denv
human
serum
depend
mbl
mbl
key
pattern
recognit
plasma
protein
complement
system
restrict
pathogen
infect
sever
mechan
includ
direct
opson
activ
lectin
complement
pathway
regul
cytokin
product
amplif
vero
cellderiv
preincub
volvol
serum
donor
absenc
presenc
increas
percentag
fresh
e
heatinactiv
f
serum
donor
without
mannos
neutral
calcul
base
reduct
number
plaqu
given
condit
compar
valu
heatinactiv
serum
donor
error
bar
indic
sem
independ
experi
perform
duplic
valu
statist
signific
differ
indic
asterisk
bracket
follow
p
p
adapt
immun
prior
studi
establish
mbl
control
wnv
infect
mice
bind
nlink
glycan
viral
structur
protein
activ
lectin
pathway
complement
result
studi
show
mbl
also
restrict
infect
denv
relat
flaviviru
human
mbl
inhibit
infect
denv
serotyp
complementdepend
complementindepend
mechan
mblmediat
neutral
denv
howev
effici
viru
gener
insect
cell
compar
viru
gener
mammalian
cell
final
concentr
mbl
human
serum
vari
among
individu
due
common
genet
polymorph
human
gene
directli
impact
neutral
denv
antibodyindepend
complementmedi
neutral
insect
celland
mammalian
cellderiv
denv
exclus
requir
mbl
neutral
denv
mbl
depend
partial
depend
factor
factor
b
yet
independ
absenc
alon
partial
reduc
neutral
wherea
combin
defici
nearli
abolish
serum
neutral
suggest
direct
bind
mbl
neutral
denv
canon
lectin
pathway
bypass
pathway
latter
mbl
bind
directli
trigger
activ
independ
result
deposit
virion
surfac
altern
pathway
complement
activ
partial
contribut
denv
neutral
presum
via
amplif
loop
lead
greater
deposit
virion
surfac
fig
natur
denv
infect
follow
bite
infect
mosquito
human
host
first
encount
insect
cellgener
viru
subsequ
round
infect
produc
viru
human
cell
contrast
observ
wnv
mbl
serum
neutral
insect
celland
mammalian
cellderiv
denv
suggest
role
mbl
control
stage
denv
infect
mbl
recogn
adjac
equatori
monosaccharid
hydroxyl
group
present
mannos
nacetylglucosamin
glcnac
fucos
commonli
found
microorgan
effici
neutral
denv
insect
cell
mammalian
cell
deriv
compar
neutral
wnv
insect
cell
deriv
mbl
may
due
addit
nlink
glycan
confer
bind
attach
factor
dcsign
uniqu
denv
among
flavivirus
result
experi
also
establish
mbl
bind
neutral
insect
cellderiv
denv
directli
absenc
complement
activ
occur
mammalian
cellderiv
denv
mbl
report
inhibit
infect
sever
type
virus
includ
filovirus
influenza
viru
hepat
c
viru
hcv
herp
simplex
viru
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
coronaviru
wnv
studi
neutral
requir
complement
activ
howev
experi
effici
recognit
insect
cellderiv
denv
purifi
human
mbl
suffici
neutral
viru
four
serotyp
independ
complement
activ
mbl
multimer
molecul
compris
two
six
subunit
tripl
helix
three
ident
polypeptid
chain
bind
mbl
denv
may
impair
host
cell
attach
andor
entri
exampl
bind
mbl
surfac
glycoprotein
influenza
viru
hcv
hiv
complementfre
system
block
viru
attach
target
cell
lack
direct
neutral
mammalian
cellderiv
denv
insect
celland
mammalian
cellderiv
wnv
mbl
despit
satur
concentr
g
ml
absenc
complement
suggest
higher
number
mblbind
site
avail
insect
cellderiv
denv
suffici
reach
threshold
requir
neutral
comparison
bind
fewer
molecul
mbl
even
low
ngml
lower
could
trigger
lectin
altern
pathway
activ
deposit
virion
surfac
promot
neutral
deposit
virion
mbldepend
lectin
pathway
activ
inhibit
wnv
infect
part
block
viral
fusion
possibl
interf
requisit
phdepend
structur
rearrang
human
concentr
mbl
plasma
vari
greatli
rang
nanogram
per
millilit
ngml
due
polymorph
promot
exon
gene
genet
variat
gene
result
human
popul
low
blood
mbl
level
ng
ml
link
increas
risk
sever
sever
infecti
diseas
review
refer
vitro
result
denv
consist
observ
provid
mechan
occur
concept
level
complement
protein
could
impact
denv
sever
new
rais
semin
studi
show
lower
level
patient
dhfdss
complement
genet
includ
mbl
variat
suscept
denv
infect
also
examin
one
studi
observ
serum
mbl
level
measur
quantit
captur
elisa
describ
materi
method
c
serum
mbl
bind
insect
cellderiv
virion
determin
use
captur
elisa
describ
legend
fig
data
mean
standard
deviat
sd
four
independ
experi
mbl
dependentserum
neutral
insect
cellderiv
perform
describ
legend
fig
neutral
calcul
base
reduct
number
plaqu
compar
valu
heatinactiv
serum
data
mean
sd
three
independ
experi
creas
risk
denvinduc
thrombocytopenia
wildtyp
lowproduc
mbl
genotyp
anoth
found
effect
mbl
variat
risk
sever
dengu
infect
howev
vast
major
patient
studi
experienc
secondari
dengu
infect
crossreact
complementfix
antibodi
present
mbl
opson
could
protect
primari
denv
infect
antidenv
antibodi
absent
low
level
yet
overshadow
secondari
denv
infect
antibodymedi
classic
pathwaydepend
complement
activ
occur
present
poorli
understood
major
almost
studi
primari
denv
infect
asymptomat
prospect
cohort
studi
children
preill
acut
plasma
sampl
requir
assess
rel
mbl
defici
impact
sever
primari
denv
infect
somewhat
surprisingli
mbl
serum
donor
variabl
neutral
four
serotyp
insectcel
deriv
denv
differenti
bind
neutral
divers
hcv
genotyp
mbl
also
observ
among
denv
serotyp
antigen
distinct
recognit
target
mbl
reli
surfaceexpos
carbohydr
extent
nlink
glycosyl
spatial
arrang
glycan
could
influenc
suscept
mbl
recognit
neutral
altern
differenti
matur
among
denv
serotyp
could
affect
retent
display
prm
glycoprotein
virion
impact
mbl
bind
neutral
studi
differ
denv
serotyp
produc
cell
overexpress
furin
plan
address
matur
impact
mbldepend
neutral
denv
neutral
studi
human
serum
contain
differ
level
mbl
readili
explain
wherea
reconstitut
serum
donor
purifi
mbl
restor
neutral
insect
cellderiv
addit
even
higher
concentr
purifi
mbl
serum
donor
fail
inhibit
mammalian
cellderiv
yet
complement
low
concentr
serum
donor
although
addit
studi
warrant
purifi
human
mbl
may
interact
downstream
complement
protein
eg
serum
donor
albeit
lower
affin
compar
nativ
mbl
donor
anoth
exampl
also
observ
differenti
neutral
capac
sera
individu
donor
donor
similar
plasma
mbl
level
differ
level
activ
contrast
wildtyp
mbl
compris
mixtur
higherord
oligom
mbl
point
mutat
variant
preferenti
form
lowmolecularmass
complex
circul
complex
bind
well
mannan
activ
lectin
pathway
less
effici
variabl
oligomer
state
circul
mbl
among
individu
independ
could
contribut
differ
rel
neutral
set
similar
mbl
level
ficolin
anoth
pattern
recognit
molecul
lectin
pathway
whose
blood
level
vari
among
individu
due
genet
polymorph
serum
masp
also
associ
ficolin
variat
ficolin
level
could
differenti
sequest
masp
explain
discord
result
overal
studi
support
hypothesi
mbl
contribut
protect
denv
infect
interplay
allel
variat
mbl
specif
viral
serotyp
type
infect
primari
versu
secondari
could
impact
sever
denv
infect
prospect
clinic
studi
warrant
investig
precis
role
mbl
defici
effect
denv
infect
human
cell
line
sera
reagent
vero
cell
grown
dulbecco
modifi
eagl
medium
dmem
sigma
supplement
fetal
bovin
serum
fb
omega
scientif
iuml
penicillin
gml
streptomycin
mm
hepe
ph
mm
nonessenti
amino
acid
cellgro
aed
albopictu
mosquito
cell
grown
sigma
medium
supplement
fb
mm
hepe
fresh
human
blood
sampl
collect
glass
tube
allow
clot
room
temperatur
minut
centrifug
g
minut
sera
aliquot
frozen
serum
sampl
thaw
day
analysi
sera
wildtyp
mice
congen
complement
fb
fd
antibodydefici
mice
obtain
previous
describ
enzon
pharmaceut
provid
purifi
recombin
human
mbl
gener
gift
blood
sampl
subject
unit
state
obtain
inform
consent
approv
washington
univers
institut
review
board
human
sampl
obtain
denmark
anonym
blood
donor
inform
consent
accord
danish
law
blood
donat
cellderiv
preincub
volvol
wildtyp
mous
serum
presenc
absenc
mannan
gml
viru
ad
vero
cell
infect
determin
hour
hour
later
focusform
assay
neutral
calcul
base
reduct
number
foci
given
condit
compar
valu
heatinactiv
hi
serum
error
bar
indic
sem
independ
experi
perform
duplic
b
cellderiv
incub
purifi
human
mbl
gml
presenc
absenc
mannan
gml
prior
addit
monolay
vero
cell
data
present
percent
neutral
percent
reduct
number
foci
compar
valu
buffer
alon
given
condit
error
bar
indic
sem
independ
experi
perform
duplic
c
cellderiv
preincub
volvol
human
serum
donor
donor
absenc
presenc
mannos
gml
purifi
human
mbl
neutral
calcul
base
reduct
number
foci
compar
valu
heatinactiv
hi
serum
error
bar
indic
sem
independ
experi
perform
duplic
valu
significantli
differ
indic
bracket
asterisk
follow
p
p
p
mbl
genotyp
singlenucleotid
polymorph
promot
region
posit
hl
variant
xy
variant
noncod
region
posit
pq
variant
codon
allel
b
allel
c
allel
exon
gene
identifi
previous
describ
viru
stock
denv
serotyp
serotyp
serotyp
unc
serotyp
wnv
new
york
propag
vero
cell
gener
insect
cellor
mammalian
cellderiv
viru
stock
respect
experi
cultur
freshli
isol
human
peripher
blood
monocyt
monocytederiv
dendrit
cell
previous
describ
viru
neutral
wnv
pfu
pfu
wnv
incub
mous
human
serum
fresh
heat
inactiv
min
purifi
recombin
human
mbl
dilut
gelatin
veron
buffer
mg
ca
gvb
complement
technolog
h
sampl
ad
monolay
cell
incub
h
cell
wash
overlaid
lowmeltingpoint
agaros
seaplaqu
lonza
minim
essenti
medium
mem
contain
fetal
bovin
serum
fb
cultur
wnv
day
follow
formaldehyd
fixat
crystal
violet
stain
plaqu
score
visual
studi
focusform
unit
ffu
viru
incub
serum
purifi
recombin
human
mbl
h
describ
sampl
ad
monolay
vero
cell
incub
h
cell
wash
overlaid
methylcellulos
mix
dmem
contain
fb
incub
hour
monolay
wash
thrice
pb
remov
methylcellulos
fix
paraformaldehyd
pb
minut
room
temperatur
rins
permeabil
perm
wash
phosphatebuff
salin
pb
saponin
bsa
infectedcel
foci
stain
incub
cell
flaviviru
crossreact
mab
gml
quantit
describ
previous
experi
virus
incub
serum
mbl
presenc
absenc
gml
mannan
mannos
prior
addit
cell
mbldenv
captur
elisa
mbl
bind
denv
evalu
use
viru
captur
elisa
mabcoat
well
microtit
plate
describ
previous
follow
modif
well
microtit
plate
adsorb
antidenv
prm
proteinspecif
mab
isotyp
control
antihepat
c
viru
mab
gml
pb
overnight
stock
dilut
dmem
pfuml
ad
well
well
plate
wash
incub
increas
concentr
purifi
human
recombin
mbl
dilut
bind
buffer
mm
trishcl
ph
tween
wtvol
bsa
nacl
mm
cacl
well
plate
wash
incub
sequenti
biotinconjug
mous
antihuman
mbl
mab
cedarlan
horseradish
peroxidas
hrp
conjug
streptavidin
develop
tmb
substrat
dako
optic
densiti
od
nm
determin
plate
reader
genio
pro
tecan
instrument
experi
captur
incub
human
serum
dilut
instead
purifi
recombin
human
mbl
neg
control
purifi
human
mbl
dilut
mm
trishcl
ph
mm
nacl
supplement
mm
edta
supplement
gml
mannan
parallel
experi
captur
denv
virion
detect
biotinyl
antidenv
eproteinspecif
mab
gml
follow
hrpconjug
streptavidin
gml
mbl
elisa
level
mbl
serum
measur
use
mbl
oligom
elisa
kit
bioporto
gentoft
denmark
accord
manufactur
instruct
hemolysi
assay
serum
serial
dilut
serum
purifi
complement
technolog
prepar
dgvb
mm
barbit
sodium
mm
dextros
mm
nacl
wtvol
gelatin
mm
cacl
mm
mgcl
ten
microlit
dilut
serum
standard
ad
tube
contain
l
dgvb
l
antibodyco
sheep
erythrocyt
ea
cellsml
complement
technolog
l
guinea
pig
serum
complement
technolog
tube
incub
minut
centrifug
minut
g
od
supernat
measur
nm
concentr
calcul
standard
curv
assay
amount
hemolyt
complement
serum
measur
method
gicla
obtain
valu
statist
analysi
data
set
compar
use
twotail
unpair
test
multipl
comparison
perform
use
analysi
varianc
anova
test
correl
coeffici
estim
base
pearson
productmo
correl
use
prism
softwar
graphpad
softwar
statist
signific
achiev
p
valu
work
support
midwest
region
center
excel
biodefens
emerg
infecti
diseas
research
cooper
agreement
henri
jackson
foundat
advanc
militari
medicin
inc
us
depart
defens
dod
p
avirutnan
support
nih
postdoctor
train
grant
divis
rheumatolog
depart
medicin
washington
univers
school
medicin
grant
mahidol
univers
grate
healthi
volunt
provid
sera
use
studi
j
brien
b
shrestha
provid
stock
pierson
fuch
experiment
advic
construct
critic
thank
omero
inc
shipment
mice
x
wu
e
moulton
dko
mice
lee
greenberg
enzon
inc
provid
purifi
human
mbl
protein
view
express
author
constru
repres
posit
us
armi
dod
supplement
materi
articl
may
found
http
mbioasmorg
figur
tif
file
mb
figur
tif
file
mb
figur
tif
file
mb
